CLARIVATE PLC
NYSE:CLVT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (0.7), the stock would be worth $5.37 (119% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.3 | $2.45 |
0%
|
| 3-Year Average | 0.7 | $5.37 |
+119%
|
| 5-Year Average | 0.8 | $6.33 |
+158%
|
| Industry Average | 0 | $0.24 |
-90%
|
| Country Average | 0 | $0.17 |
-93%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| UK |
|
CLARIVATE PLC
NYSE:CLVT
|
1.6B USD | 0.3 | -7.8 | |
| UK |
|
Relx PLC
LSE:REL
|
49B GBP | 20.7 | 23.7 | |
| UK |
I
|
IHS Markit Ltd
F:0M3
|
37.9B EUR | 4.6 | 36.5 | |
| CA |
|
Thomson Reuters Corp
TSX:TRI
|
55B CAD | 3.3 | 26.1 | |
| IE |
|
Experian PLC
LSE:EXPN
|
25.1B GBP | 6.2 | 24.6 | |
| US |
|
Verisk Analytics Inc
NASDAQ:VRSK
|
24.6B USD | 79.7 | 27.1 | |
| CH |
|
SGS SA
SIX:SGSN
|
16.5B CHF | 18.2 | 24.6 | |
| US |
|
Equifax Inc
NYSE:EFX
|
20.6B USD | 4.5 | 29.4 | |
| US |
|
Leidos Holdings Inc
NYSE:LDOS
|
18.5B USD | 3.8 | 12.7 | |
| US |
U
|
UL Solutions Inc
NYSE:ULS
|
18.1B USD | 0 | 0 | |
| NL |
|
Wolters Kluwer NV
AEX:WKL
|
15B EUR | 18.8 | 11.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 0 |
| Median | 0 |
| 70th Percentile | 0 |
| Max | 49 422.3 |
Other Multiples
CLARIVATE PLC
Glance View
Founded with a vision to transform the vast world of information into a wellspring of actionable insights, Clarivate PLC has curated an impressive journey in the realm of data and analytics. The company emerged as a pivotal player by offering a suite of products and services designed to assist organizations in harnessing the power of data. Specializing in innovation lifecycle management, Clarivate provides crucial insights that fuel research and development across industries, empowering clients to make informed decisions. The firm's expansive portfolio, encompassing brands like Web of Science, Cortellis, and Derwent, stands as a testament to its commitment to delivering high-quality, data-driven solutions. Clarivate thrives financially by licensing its data-driven platforms and analytics tools, enabling clients to navigate challenges in a data-intensive world. The company's subscription-based model ensures a continuous revenue stream, complimented by its ability to tailor solutions to meet the evolving demands of its diverse clientele. By facilitating access to critical scientific and academic content, providing insights into intellectual property, and enhancing competitive analysis frameworks, Clarivate positions itself not merely as a data provider but as an indispensable partner in the strategic growth of businesses worldwide. The firm's ongoing pursuit of innovation ensures that it remains ahead in a rapidly evolving market, maintaining its role as a key enabler of knowledge-driven success.